10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q2 2012

Filing Information

Form Type	10-Q
Accession Number	`0001104659-12-056527`
Period End Date	20120630
Filing Date	20120809
Fiscal Year	2012
Fiscal Period	Q2
XBRL Instance	cldx-20120630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 70 Income Statement 74 Cash Flow Statement 63

Balance Sheet 70 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.90M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.83M	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$18.56M	USD	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$60.11M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$41.41M	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$61.00K	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	58.75M	shares	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$170.00K	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	44.21M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	44.21M	shares	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.20M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	58.75M	shares	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.67M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$80.40M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$54.68M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$9.09M	USD	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$8.00M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$24.92M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$24.34M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$329.00K	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$428.00K	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Total Assets	`Assets`	$122.13M	USD	Point-in-time
Total Assets	`Assets`	$97.99M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$395.00K	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$935.00K	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$7.01M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$6.55M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$335.00K	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$219.00K	USD	Point-in-time
Current Portion of Term Loan	`SecuredDebtCurrent`	$6.14M	USD	Point-in-time
Current Portion of Term Loan	`SecuredDebtCurrent`	$5.29M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$14.30M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$12.58M	USD	Point-in-time
Term Loan, less Current Portion	`SecuredLongTermDebt`	$8.61M	USD	Point-in-time
Term Loan, less Current Portion	`SecuredLongTermDebt`	$9.01M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$6.39M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$5.97M	USD	Point-in-time
Total Liabilities	`Liabilities`	$29.27M	USD	Point-in-time
Total Liabilities	`Liabilities`	$27.58M	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2012 and December 31, 2011	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2012 and December 31, 2011	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 58,753,571 and 44,210,636 Shares Issued and Outstanding at June 30, 2012 and December 31, 2011, respectively	`CommonStockValue`	$44.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 58,753,571 and 44,210,636 Shares Issued and Outstanding at June 30, 2012 and December 31, 2011, respectively	`CommonStockValue`	$59.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$271.03M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$324.06M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.72M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.65M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-205.01M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-232.29M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$94.55M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$68.72M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$97.99M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$122.13M	USD	Point-in-time

Income Statement 74 line items

Line Item	Tag	Value	Unit	Period
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$40.00K	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$11.00K	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$75.00K	USD	2 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$25.00K	USD	2 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$96.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$149.00K	USD	2 Qtrs
Product Royalties	`RoyaltyRevenue`	$1.94M	USD	1 Quarter
Product Royalties	`RoyaltyRevenue`	$4.44M	USD	2 Qtrs
Product Royalties	`RoyaltyRevenue`	$4.22M	USD	2 Qtrs
Product Royalties	`RoyaltyRevenue`	$1.87M	USD	1 Quarter
Total Revenue	`Revenues`	$4.44M	USD	2 Qtrs
Total Revenue	`Revenues`	$1.95M	USD	1 Quarter
Total Revenue	`Revenues`	$2.01M	USD	1 Quarter
Total Revenue	`Revenues`	$4.47M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$7.17M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$11.11M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$21.88M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$14.02M	USD	2 Qtrs
Royalty	`RoyaltyExpense`	$4.22M	USD	2 Qtrs
Royalty	`RoyaltyExpense`	$1.94M	USD	1 Quarter
Royalty	`RoyaltyExpense`	$4.44M	USD	2 Qtrs
Royalty	`RoyaltyExpense`	$1.87M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$2.22M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$2.24M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$4.54M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$4.58M	USD	2 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$291.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$966.00K	USD	2 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$583.00K	USD	2 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$483.00K	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$15.50M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$24.01M	USD	2 Qtrs
Total Operating Expense	`CostsAndExpenses`	$11.83M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$31.22M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-19.54M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-26.78M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-9.88M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-13.49M	USD	1 Quarter
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$126.00K	USD	1 Quarter
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$163.00K	USD	2 Qtrs
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$79.00K	USD	1 Quarter
Investment and Other Income, Net	`NonoperatingIncomeExpense`	$331.00K	USD	2 Qtrs
Interest Expense	`InterestExpense`	$920.00K	USD	2 Qtrs
Interest Expense	`InterestExpense`	$844.00K	USD	2 Qtrs
Interest Expense	`InterestExpense`	$434.00K	USD	1 Quarter
Interest Expense	`InterestExpense`	$411.00K	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-20.30M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-27.29M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.24M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-13.77M	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.58	USD	2 Qtrs
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.23	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.27	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.50	USD	2 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	58.73M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	54.44M	shares	2 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	37.46M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	34.77M	shares	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-20.30M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-27.29M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.24M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-13.77M	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-1.00K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-5.00K	USD	2 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-1.00K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$1.00K	USD	2 Qtrs
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-39.00K	USD	1 Quarter
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$69.00K	USD	2 Qtrs
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$15.00K	USD	1 Quarter
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$28.00K	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-20.27M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-13.81M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-27.22M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-10.22M	USD	1 Quarter

Cash Flow Statement 63 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-20.30M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-27.29M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-10.24M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-13.77M	USD	1 Quarter
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.07M	USD	2 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.13M	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$291.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$966.00K	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$583.00K	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$483.00K	USD	1 Quarter
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$157.00K	USD	2 Qtrs
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$242.00K	USD	2 Qtrs
Realized (Gain) Loss on Sales and Maturities of Marketable Securities	`MarketableSecuritiesGainLoss`	$6.00K	USD	2 Qtrs
Realized (Gain) Loss on Sales and Maturities of Marketable Securities	`MarketableSecuritiesGainLoss`	$-8.00K	USD	2 Qtrs
Gain on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$12.00K	USD	2 Qtrs
Gain on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$55.00K	USD	2 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$1.13M	USD	2 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$1.09M	USD	2 Qtrs
Non-Cash Interest Expense	`AmortizationOfDebtDiscountPremium`	$192.00K	USD	2 Qtrs
Non-Cash Interest Expense	`AmortizationOfDebtDiscountPremium`	$111.00K	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-109.00K	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-161.00K	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$408.00K	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$493.00K	USD	2 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$4.00K	USD	2 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$99.00K	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-993.00K	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-937.00K	USD	2 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$573.00K	USD	2 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$122.00K	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-25.51M	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-18.23M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$20.92M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$18.39M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$39.38M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$38.73M	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$282.00K	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$122.00K	USD	2 Qtrs
Proceeds from Sale or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$156.00K	USD	2 Qtrs
Proceeds from Sale or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$64.00K	USD	2 Qtrs
Net Cash Used in Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-20.55M	USD	2 Qtrs
Net Cash Used in Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-18.43M	USD	2 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$35.89M	USD	2 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$51.96M	USD	2 Qtrs
(Payments) Issuance of Term Loan	`ProceedsFromIssuanceOfLongTermDebt`	$-1.32M	USD	2 Qtrs
(Payments) Issuance of Term Loan	`ProceedsFromIssuanceOfLongTermDebt`	$5.00M	USD	2 Qtrs
Payment of Convertible Subordinated Debt	`RepaymentsOfConvertibleDebt`	$12.50M	USD	2 Qtrs
Payments of Other Liabilities	`RepaymentsOfOtherLongTermDebt`	$58.00K	USD	2 Qtrs
Payments of Other Liabilities	`RepaymentsOfOtherLongTermDebt`	$29.00K	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$50.60M	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$28.33M	USD	2 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$1.00K	USD	2 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-5.00K	USD	2 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-10.46M	USD	2 Qtrs
Net Increase (Decrease) in Cash and Cash Equivalents	`NetCashProvidedByUsedInContinuingOperations`	$6.66M	USD	2 Qtrs
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.90M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$10.83M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$18.56M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$21.29M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.90M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$10.83M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$18.56M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.